| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,569 |
8,752 |
$629K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,569 |
7,792 |
$403K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
678 |
647 |
$58K |
| 90834 |
Psychotherapy, 45 minutes with patient |
714 |
437 |
$50K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,286 |
1,270 |
$47K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
379 |
373 |
$29K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,613 |
1,563 |
$24K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
2,316 |
2,277 |
$23K |
| 36415 |
Collection of venous blood by venipuncture |
8,261 |
7,606 |
$21K |
| 99215 |
Prolong outpt/office vis |
138 |
134 |
$18K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
510 |
481 |
$16K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
492 |
468 |
$12K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
144 |
141 |
$11K |
| 90686 |
|
1,546 |
1,519 |
$11K |
| 80061 |
Lipid panel |
648 |
631 |
$9K |
| X5622 |
|
841 |
823 |
$7K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
72 |
65 |
$7K |
| 84443 |
Thyroid stimulating hormone (TSH) |
387 |
380 |
$7K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
845 |
782 |
$5K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
506 |
498 |
$5K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
103 |
100 |
$4K |
| 0001A |
|
114 |
113 |
$3K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
53 |
51 |
$3K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
354 |
340 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
291 |
277 |
$3K |
| 92551 |
|
536 |
530 |
$3K |
| 0002A |
|
98 |
97 |
$3K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
76 |
69 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
131 |
125 |
$3K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
59 |
54 |
$2K |
| 90717 |
|
14 |
14 |
$2K |
| 0012A |
|
82 |
81 |
$2K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
13 |
13 |
$1K |
| 99188 |
|
193 |
191 |
$1K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
41 |
39 |
$1K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
15 |
15 |
$1K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
26 |
26 |
$1K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
24 |
24 |
$1K |
| 0011A |
|
68 |
68 |
$919.56 |
| 85018 |
|
352 |
342 |
$795.55 |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
15 |
13 |
$736.18 |
| 59025 |
Fetal non-stress test |
64 |
49 |
$666.53 |
| 90715 |
|
26 |
25 |
$589.22 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
66 |
65 |
$574.69 |
| 0064A |
|
15 |
15 |
$571.80 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
37 |
36 |
$561.69 |
| 80053 |
Comprehensive metabolic panel |
55 |
51 |
$557.21 |
| 81001 |
|
194 |
183 |
$550.37 |
| 99173 |
|
486 |
480 |
$517.16 |
| 0071A |
|
26 |
13 |
$513.24 |
| 86780 |
|
36 |
36 |
$490.51 |
| 73630 |
|
14 |
12 |
$380.24 |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
12 |
12 |
$317.12 |
| 99401 |
|
12 |
12 |
$298.98 |
| 99000 |
|
55 |
50 |
$200.00 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
25 |
25 |
$185.13 |
| 87081 |
|
56 |
54 |
$176.38 |
| 96127 |
|
52 |
52 |
$165.41 |
| 85027 |
|
14 |
13 |
$89.71 |
| 36416 |
|
12 |
12 |
$83.87 |
| 90656 |
|
13 |
13 |
$47.76 |
| G0008 |
Administration of influenza virus vaccine |
126 |
126 |
$0.00 |
| 90723 |
|
12 |
12 |
$0.00 |
| 90670 |
|
78 |
76 |
$0.00 |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
12 |
12 |
$0.00 |
| 90633 |
|
12 |
12 |
$0.00 |